메뉴 건너뛰기




Volumn 176, Issue 2 A, 1998, Pages 68S-73S

Clinical safety of becaplermin (rhPDGF-BB) gel

Author keywords

[No Author keywords available]

Indexed keywords

BECAPLERMIN; RECOMBINANT PLATELET DERIVED GROWTH FACTOR; UNCLASSIFIED DRUG;

EID: 0031713762     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(98)00174-3     Document Type: Article
Times cited : (53)

References (11)
  • 1
    • 0003717478 scopus 로고    scopus 로고
    • Atlanta, GA: US Department of Health and Human Services, Public Health Services
    • National Diabetes Fact Sheet. Atlanta, GA: US Department of Health and Human Services, Public Health Services; 1997.
    • (1997) National Diabetes Fact Sheet
  • 2
    • 0003128203 scopus 로고
    • Lower extremity foot ulcers and amputations in diabetes
    • Harris MI, Cowie CC, Reiber G, Boyko E, Stern M, Bennett P, eds. Washington, DC: US Government Printing Office
    • Reiber GE, Boyko EJ, Smith DG. Lower extremity foot ulcers and amputations in diabetes. In: Harris MI, Cowie CC, Reiber G, Boyko E, Stern M, Bennett P, eds. Diabetes in America. Washington, DC: US Government Printing Office, 1995:409-428.
    • (1995) Diabetes in America , pp. 409-428
    • Reiber, G.E.1    Boyko, E.J.2    Smith, D.G.3
  • 3
    • 0002714577 scopus 로고
    • Peripheral vascular disease and diabetes
    • Harris MI, Hamman RF, eds. Washington, DC: US Government Printing Office
    • Palumbo PJ, Melton LJ III. Peripheral vascular disease and diabetes. In: Harris MI, Hamman RF, eds. Diabetes in America. Washington, DC: US Government Printing Office, 1985:1-21.
    • (1985) Diabetes in America , pp. 1-21
    • Palumbo, P.J.1    Melton L.J. III2
  • 5
    • 0024758199 scopus 로고
    • Amputation in the diabetic population: Incidence, causes, cost, treatment, and prevention
    • Fylling CP, Knighton DR. Amputation in the diabetic population: incidence, causes, cost, treatment, and prevention. J Enterostomal Ther. 1989;16:247-255.
    • (1989) J Enterostomal Ther. , vol.16 , pp. 247-255
    • Fylling, C.P.1    Knighton, D.R.2
  • 7
    • 0022457822 scopus 로고
    • The biology of platelet-derived growth factor
    • Ross R, Raines EW, Bowen-Pope DF. The biology of platelet-derived growth factor. Cell 1986;46:155-169.
    • (1986) Cell , vol.46 , pp. 155-169
    • Ross, R.1    Raines, E.W.2    Bowen-Pope, D.F.3
  • 8
    • 0024383718 scopus 로고
    • Peptide regulatory factors. Platelet-derived growth factor
    • Ross R. Peptide regulatory factors. Platelet-derived growth factor. Lancet. 1989;i:1179-1989.
    • (1989) Lancet , vol.1 , pp. 1179-1989
    • Ross, R.1
  • 9
    • 0025894052 scopus 로고
    • Role of platelet-derived growth factor in wound healing
    • Pierce GF, Mustoe TA, Altrock BW, et al. Role of platelet-derived growth factor in wound healing. J Cell Biochem. 1991;45: 319-326.
    • (1991) J Cell Biochem. , vol.45 , pp. 319-326
    • Pierce, G.F.1    Mustoe, T.A.2    Altrock, B.W.3
  • 10
    • 0027957730 scopus 로고
    • Role of growth factors in cutaneous wound healing: A review
    • Kiritsy CP, Lynch AB, Lynch SE. Role of growth factors in cutaneous wound healing: a review. Crit Rev Oral Biol Med. 1993; 4:729-760.
    • (1993) Crit Rev Oral Biol Med. , vol.4 , pp. 729-760
    • Kiritsy, C.P.1    Lynch, A.B.2    Lynch, S.E.3
  • 11
    • 0031688508 scopus 로고    scopus 로고
    • A review of nonclinical toxicology studies of becaplermin (rhPDGF-BB)
    • Knight EV, Oldham JW, Mohler MA, Liu S, Dooley J. A review of nonclinical toxicology studies of becaplermin (rhPDGF-BB). Am J Surg. 1998;176(Suppl. 2A):61S-66S.
    • (1998) Am J Surg. , vol.176 , Issue.SUPPL. 2A
    • Knight, E.V.1    Oldham, J.W.2    Mohler, M.A.3    Liu, S.4    Dooley, J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.